A New Treatment in Multiple Sclerosis: Daclizumab High Yield Process

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:180 / 181
页数:2
相关论文
共 50 条
  • [1] Daclizumab high-yield process in the treatment of relapsing-remitting multiple sclerosis
    Preiningerova, Jana Lizrova
    Vachova, Marta
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (01) : 67 - 75
  • [2] Population pharmacokinetics of daclizumab high-yield process (HYP) in subjects with multiple sclerosis
    Diao, L.
    Hang, Y.
    Othman, A. A.
    Nestorov, I.
    Tran, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 441 - 441
  • [3] Daclizumab in multiple sclerosis: a high-yield extension study
    Barkhof, Frederik
    Ciccarelli, Olga
    LANCET NEUROLOGY, 2014, 13 (05): : 443 - +
  • [4] Daclizumab Treatment for Multiple Sclerosis
    Kim, Sylvia E.
    PHARMACOTHERAPY, 2009, 29 (02): : 227 - 235
  • [5] Treatment of multiple sclerosis with daclizumab
    Rose, JW
    Watt, HE
    White, A
    Martin, R
    NEUROLOGY, 2004, 62 (07) : A98 - A98
  • [6] Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)
    Kappos, L.
    Wiendl, H.
    Kaufman, M.
    Rose, J.
    Havrdova, E.
    Boyko, A.
    Eraksoy, M.
    Sheridan, J.
    Elkins, J.
    O'Neil, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 234 - 234
  • [7] Daclizumab in the treatment of patients with multiple sclerosis
    Ali, Eman N.
    Stazzone, Lynn A.
    Brown, Brandon A.
    Weiner, Howard
    Khoury, Samia
    NEUROLOGY, 2007, 68 (12) : A85 - A85
  • [8] Daclizumab in treatment of multiple sclerosis patients
    Ali, E. N.
    Healy, B. C.
    Stazzone, L. A.
    Brown, B. A.
    Weiner, H. L.
    Khoury, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (02) : 272 - 274
  • [9] Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis
    Gavin Giovannoni
    Ernst-Wilhelm Radue
    Eva Havrdova
    Katherine Riester
    Steven Greenberg
    Lahar Mehta
    Jacob Elkins
    Journal of Neurology, 2014, 261 : 316 - 323
  • [10] Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis
    Giovannoni, Gavin
    Radue, Ernst-Wilhelm
    Havrdova, Eva
    Riester, Katherine
    Greenberg, Steven
    Mehta, Lahar
    Elkins, Jacob
    JOURNAL OF NEUROLOGY, 2014, 261 (02) : 316 - 323